BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Efe C, Purnak T, Ozaslan E, Ozbalkan Z, Karaaslan Y, Altiparmak E, Muratori P, Wahlin S. Autoimmune liver disease in patients with systemic lupus erythematosus: a retrospective analysis of 147 cases. Scand J Gastroenterol 2011;46:732-7. [PMID: 21348808 DOI: 10.3109/00365521.2011.558114] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Alves SC, Fasano S, Isenberg DA. Autoimmune gastrointestinal complications in patients with systemic lupus erythematosus: case series and literature review. Lupus 2016;25:1509-19. [PMID: 27329649 DOI: 10.1177/0961203316655210] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
2 Pelka K, Stec-Polak M, Wojas-Pelc A, Pastuszczak M. Prevalence of antimitochondrial antibodies in subacute cutaneous lupus erythematosus. Int J Dermatol 2021;60:88-92. [PMID: 33017043 DOI: 10.1111/ijd.15225] [Reference Citation Analysis]
3 Huang YQ. Current progress in research of overlap syndrome of autoimmune liver diseases. Shijie Huaren Xiaohua Zazhi 2014; 22(3): 301-309 [DOI: 10.11569/wcjd.v22.i3.301] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Efe C, Wahlin S, Ozaslan E, Berlot AH, Purnak T, Muratori L, Quarneti C, Yüksel O, Thiéfin G, Muratori P. Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome and associated extrahepatic autoimmune diseases. Eur J Gastroenterol Hepatol 2012;24:531-4. [PMID: 22465972 DOI: 10.1097/MEG.0b013e328350f95b] [Cited by in Crossref: 65] [Cited by in F6Publishing: 20] [Article Influence: 6.5] [Reference Citation Analysis]
5 AlAhmed O, Sivaraman V, Moore-Clingenpeel M, Ardoin SP, Bout-Tabaku S; CARRA registry investigators. Autoimmune thyroid diseases, autoimmune hepatitis, celiac disease and type 1 diabetes mellitus in pediatric systemic lupus erythematosus: Results from the CARRA Legacy Registry. Lupus 2020;29:1926-36. [PMID: 33016198 DOI: 10.1177/0961203320961469] [Reference Citation Analysis]
6 Picceli V, Skare T, Nisihara R, Kotze L, Messias-reason I, Utiyama S. Spectrum of autoantibodies for gastrointestinal autoimmune diseases in systemic lupus erythematosus patients. Lupus 2013;22:1150-5. [DOI: 10.1177/0961203313503911] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
7 Spârchez M, Lupan I, Delean D, Bizo A, Damian L, Muntean L, Tămaș MM, Bolba C, Simionescu B, Slăvescu C, Felea I, Lazăr C, Spârchez Z, Rednic S. Primary complement and antibody deficiencies in autoimmune rheumatologic diseases with juvenile onset: a prospective study at two centers. Pediatr Rheumatol Online J 2015;13:51. [PMID: 26590091 DOI: 10.1186/s12969-015-0050-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
8 Bessone F, Poles N, Roma MG. Challenge of liver disease in systemic lupus erythematosus: Clues for diagnosis and hints for pathogenesis. World J Hepatol 2014; 6(6): 394-409 [PMID: 25018850 DOI: 10.4254/wjh.v6.i6.394] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
9 Heijke R, Ahmad A, Frodlund M, Wirestam L, Dahlström Ö, Dahle C, Kechagias S, Sjöwall C. Usefulness of Clinical and Laboratory Criteria for Diagnosing Autoimmune Liver Disease among Patients with Systemic Lupus Erythematosus: An Observational Study. J Clin Med 2021;10:3820. [PMID: 34501268 DOI: 10.3390/jcm10173820] [Reference Citation Analysis]
10 Fan X, Men R, Ni P, Lu C, Si T, Ma Y, Yang L. Concomitant systemic lupus erythematosus might have a negative impact on the biochemical responses to treatment in patients with primary biliary cholangitis. Clin Rheumatol 2020;39:795-803. [DOI: 10.1007/s10067-019-04853-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Wang CR, Tsai HW. Autoimmune liver diseases in systemic rheumatic diseases. World J Gastroenterol 2022; 28(23): 2527-2545 [DOI: 10.3748/wjg.v28.i23.2527] [Reference Citation Analysis]
12 Beisel C, Weiler-Normann C, Teufel A, Lohse AW. Association of autoimmune hepatitis and systemic lupus erythematodes: A case series and review of the literature. World J Gastroenterol 2014; 20(35): 12662-12667 [PMID: 25253972 DOI: 10.3748/wjg.v20.i35.12662] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
13 Aksoy EK, Yilmaz B, Köklü S. Autoimmune hepatitis/primary biliary cirrhosis overlap syndrome developed in a patient with vitiligo and Hashimoto thyroiditis. Eur J Gastroenterol Hepatol. 2013;25:121-122. [PMID: 23196727 DOI: 10.1097/MEG.0b013e328359493e] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
14 Shizuma T. Clinical Characteristics of Concomitant Systemic Lupus Erythematosus and Primary Biliary Cirrhosis: A Literature Review. J Immunol Res 2015;2015:713728. [PMID: 26090497 DOI: 10.1155/2015/713728] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
15 Hammami S, Chaabane N, Mahmoudi H, Bdioui F, Saffar H. Late-onset systemic lupus erythematosus-associated primary biliary cirrhosis. Int Arch Med 2013;6:3. [PMID: 23383854 DOI: 10.1186/1755-7682-6-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
16 Wang L, Zhang FC, Chen H, Zhang X, Xu D, Li YZ, Wang Q, Gao LX, Yang YJ, Kong F, Wang K. Connective tissue diseases in primary biliary cirrhosis: A population-based cohort study. World J Gastroenterol 2013; 19(31): 5131-5137 [PMID: 23964148 DOI: 10.3748/wjg.v19.i31.5131] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
17 El Shazly RI, Mohammed WHS, Mohamed SF, Elnasr MIS. Prevalence and risk factors of liver biochemical abnormalities in patients with systemic lupus erythematosus. Egypt Rheumatol Rehabil 2014;41:139-47. [DOI: 10.4103/1110-161x.147352] [Reference Citation Analysis]
18 Brynskov J. This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 2011;46:1281-2. [DOI: 10.3109/00365521.2011.618033] [Reference Citation Analysis]
19 Gebreselassie A, Aduli F, Howell CD. Rheumatologic Diseases and the Liver. Clinics in Liver Disease 2019;23:247-61. [DOI: 10.1016/j.cld.2018.12.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
20 You H, Peng L, Zhao J, Fei Y, Wang Q, Zhang W, Li M, Zeng X. Clinical Characteristics of Systemic Lupus Erythematosus with Cirrhosis. J Immunol Res 2020;2020:2156762. [PMID: 32537465 DOI: 10.1155/2020/2156762] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Adiga A, Nugent K. Lupus Hepatitis and Autoimmune Hepatitis (Lupoid Hepatitis). The American Journal of the Medical Sciences 2017;353:329-35. [DOI: 10.1016/j.amjms.2016.10.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
22 González-Regueiro JA, Cruz-Contreras M, Merayo-Chalico J, Barrera-Vargas A, Ruiz-Margáin A, Campos-Murguía A, Espin-Nasser M, Martínez-Benítez B, Méndez-Cano VH, Macías-Rodríguez RU. Hepatic manifestations in systemic lupus erythematosus. Lupus 2020;29:813-24. [PMID: 32390496 DOI: 10.1177/0961203320923398] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Önder FO, Yürekli ÖT, Öztaş E, Kalkan İH, Köksal AŞ, Akdoğan M, Şaşmaz N, Kayaçetin E. Features of systemic lupus erythematosus in patients with autoimmune hepatitis. Rheumatol Int 2013;33:1581-5. [DOI: 10.1007/s00296-012-2607-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
24 Ali AH, Carey EJ, Lindor KD. The management of autoimmunity in patients with cholestatic liver diseases. Expert Review of Gastroenterology & Hepatology 2015;10:73-91. [DOI: 10.1586/17474124.2016.1095088] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
25 French JB, Bonacini M, Ghabril M, Foureau D, Bonkovsky HL. Hepatotoxicity Associated with the Use of Anti-TNF-α Agents. Drug Saf 2016;39:199-208. [PMID: 26692395 DOI: 10.1007/s40264-015-0366-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
26 Lim D, Kim Y, Lee D, Min Ahn S, Hong S, Lee C, Yoo B. Immunoglobulin G Levels as a Prognostic Factor for Autoimmune Hepatitis Combined With Systemic Lupus Erythematosus: Autoimmune Hepatitis in SLE. Arthritis Care & Research 2016;68:995-1002. [DOI: 10.1002/acr.22800] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]